Latest Breaking News On - Tarsus pharmaceuticals inc - Page 2 : comparemela.com

These Are the Most Heavily Shorted Stocks Heating Up the Market

These Are the Most Heavily Shorted Stocks Heating Up the Market
247wallst.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from 247wallst.com Daily Mail and Mail on Sunday newspapers.

Jonathan weiss shutterstockArbor realty trust incHoldings incCarvana coOlema pharmaceuticals incNine energy service incSunnova energy international incFortress energy incEditas medicine incZentalis pharmaceuticals incPhathom pharmaceuticals incVital energy incReneo pharmaceuticals incRobot corporationPetco healthProperties trust inc

Tarsus Pharmaceuticals (NASDAQ:TARS) Shares Up 5 8% After Analyst Upgrade

Tarsus Pharmaceuticals (NASDAQ:TARS) Shares Up 5 8% After Analyst Upgrade
dailypolitical.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailypolitical.com Daily Mail and Mail on Sunday newspapers.

United statesSeshadri neervannanBobakr azamianSecurities exchange commissionTarsus pharmaceuticals incTarsus pharmaceuticalsAllspring global investments holdingsIeq capitalSwiss national bankJefferies financial groupInsider transactions at tarsus pharmaceuticalsNews ratings for tarsus pharmaceuticals dailyConnor clark lunn investment management ltdArtisan partners limited partnershipGoldman sachs groupHedge funds weigh in on tarsus pharmaceuticals

Tarsus Pharmaceuticals (NASDAQ:TARS) Trading 5 8% Higher After Analyst Upgrade

Tarsus Pharmaceuticals (NASDAQ:TARS) Trading 5 8% Higher After Analyst Upgrade
tickerreport.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tickerreport.com Daily Mail and Mail on Sunday newspapers.

United statesBobakr azamianBryan wahlJefferies financial groupFinancial servicesBleakley financial groupNews ratings for tarsus pharmaceuticals dailyInsider activity at tarsus pharmaceuticalsGoldman sachs groupTarsus pharmaceuticals company profileProshare advisorsTarsus pharmaceuticals stock performanceRussell investments group ltdSecurities exchange commissionLord abbettInstitutional trading of tarsus pharmaceuticals

Oppenheimer Raises Tarsus Pharmaceuticals (NASDAQ:TARS) Price Target to $61 00

Oppenheimer Raises Tarsus Pharmaceuticals (NASDAQ:TARS) Price Target to $61 00
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

United statesAziz mottiwalaSeshadri neervannanFinancial servicesProshare advisorsNews ratings for tarsus pharmaceuticals dailyTarsus pharmaceuticals incTarsus pharmaceuticals company profileAnalyst recommendations for tarsus pharmaceuticalsGoldman sachs groupBleakley financial groupSecurities exchange commissionLord abbettTarsus pharmaceuticals stock performanceTarsus pharmaceuticalsInstitutional trading of tarsus pharmaceuticals

Tarsus Pharmaceuticals, Inc (NASDAQ:TARS) Stake Decreased by Vivo Capital LLC

Tarsus Pharmaceuticals, Inc (NASDAQ:TARS) Stake Decreased by Vivo Capital LLC
dailypolitical.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailypolitical.com Daily Mail and Mail on Sunday newspapers.

United statesZurcher kantonalbank zurich cantonalbankSeshadri neervannanBryan wahlMirae asset global investments coTarsus pharmaceuticals incHoldings channelGoldman sachs groupTarsus pharmaceuticals stock performanceNews ratings for tarsus pharmaceuticals dailyTarsus pharmaceuticals profileJefferies financial groupChina universal asset management coVivo capitalQuarter for tarsus pharmaceuticalsRaymond james associates